- Home
- DCOM vs SVRA Comparison
DCOM vs SVRA Comparison
Compare DCOM & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCOM | SVRA |
|---|---|---|
| Founded | 1864 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | DCOM | SVRA |
|---|---|---|
| Price | $29.10 | $5.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $34.17 | $6.88 |
| AVG Volume (30 Days) | 265.7K | ★ 2.2M |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $340,529,000.00 | N/A |
| Revenue This Year | $52.73 | N/A |
| Revenue Next Year | $16.33 | N/A |
| P/E Ratio | $24.90 | ★ N/A |
| Revenue Growth | ★ 8.54 | N/A |
| 52 Week Low | $23.25 | $1.89 |
| 52 Week High | $37.13 | $6.37 |
Technical Indicators
Market Signals| Indicator | DCOM | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 62.64 | 74.17 |
| Support Level | $27.81 | $5.09 |
| Resistance Level | $29.06 | $6.37 |
| Average True Range (ATR) | 1.04 | 0.39 |
| MACD | 0.38 | 0.15 |
| Stochastic Oscillator | 94.66 | 82.26 |
Price Performance
Historical ComparisonAbout DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.